Erratum to “Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma” [Diagn. Interv. Imaging 98 (12) (2017) 827–35](S2211568417302784)(10.1016/j.diii.2017.10.010)

Yusuke Matsui, A. Figi, M. Horikawa, Y. Jahangiri Noudeh, Y. Tomozawa, K. Hashimoto, J. A. Kaufman, K. Farsad

Research output: Contribution to journalComment/debate

Abstract

In their article, the authors wish to correct the presentation of Table 1. In addition, the authors wish to complete their disclosure statement. Disclosure of interests: Activities related to the present article: K.F. received a grant from Guerbet for this study. Activities not related to the present article: Y.M. a grant from Japan Radiological Society supported by Bayer Yakuhin; a consultancy fee from Stryker Japan; a lecture's fee from Terumo Corporation. J.A.K. grants from NIH, WL Gore, and BTG; personal fees from VIVA Physicians, Delcath, MarrowStim and COOK Medical; book royalties and journal editor stipend from Elsevier; section editor stipend from ARRS/AJR; stock ownership in Hatch Medical, Vu Medi, Endoshape, and Veniti; stock options in Javelin Medical, AV Medical, and BIO2 Medical. A.F., M.H., Y.J., Y.T., and K.H. declare that they have no competing interest.

Original languageEnglish
Pages (from-to)183-184
Number of pages2
JournalDiagnostic and interventional imaging
Volume99
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Fees and Charges
Organized Financing
Hepatocellular Carcinoma
Disclosure
Japan
Ownership
Physicians

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

Erratum to “Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma” [Diagn. Interv. Imaging 98 (12) (2017) 827–35](S2211568417302784)(10.1016/j.diii.2017.10.010). / Matsui, Yusuke; Figi, A.; Horikawa, M.; Jahangiri Noudeh, Y.; Tomozawa, Y.; Hashimoto, K.; Kaufman, J. A.; Farsad, K.

In: Diagnostic and interventional imaging, Vol. 99, No. 3, 01.03.2018, p. 183-184.

Research output: Contribution to journalComment/debate

@article{c4caf518af9948e3a5861037ad1c69b3,
title = "Erratum to “Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma” [Diagn. Interv. Imaging 98 (12) (2017) 827–35](S2211568417302784)(10.1016/j.diii.2017.10.010)",
abstract = "In their article, the authors wish to correct the presentation of Table 1. In addition, the authors wish to complete their disclosure statement. Disclosure of interests: Activities related to the present article: K.F. received a grant from Guerbet for this study. Activities not related to the present article: Y.M. a grant from Japan Radiological Society supported by Bayer Yakuhin; a consultancy fee from Stryker Japan; a lecture's fee from Terumo Corporation. J.A.K. grants from NIH, WL Gore, and BTG; personal fees from VIVA Physicians, Delcath, MarrowStim and COOK Medical; book royalties and journal editor stipend from Elsevier; section editor stipend from ARRS/AJR; stock ownership in Hatch Medical, Vu Medi, Endoshape, and Veniti; stock options in Javelin Medical, AV Medical, and BIO2 Medical. A.F., M.H., Y.J., Y.T., and K.H. declare that they have no competing interest.",
author = "Yusuke Matsui and A. Figi and M. Horikawa and {Jahangiri Noudeh}, Y. and Y. Tomozawa and K. Hashimoto and Kaufman, {J. A.} and K. Farsad",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.diii.2018.01.015",
language = "English",
volume = "99",
pages = "183--184",
journal = "Diagnostic and interventional imaging",
issn = "2211-5684",
publisher = "Elsevier Masson",
number = "3",

}

TY - JOUR

T1 - Erratum to “Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma” [Diagn. Interv. Imaging 98 (12) (2017) 827–35](S2211568417302784)(10.1016/j.diii.2017.10.010)

AU - Matsui, Yusuke

AU - Figi, A.

AU - Horikawa, M.

AU - Jahangiri Noudeh, Y.

AU - Tomozawa, Y.

AU - Hashimoto, K.

AU - Kaufman, J. A.

AU - Farsad, K.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - In their article, the authors wish to correct the presentation of Table 1. In addition, the authors wish to complete their disclosure statement. Disclosure of interests: Activities related to the present article: K.F. received a grant from Guerbet for this study. Activities not related to the present article: Y.M. a grant from Japan Radiological Society supported by Bayer Yakuhin; a consultancy fee from Stryker Japan; a lecture's fee from Terumo Corporation. J.A.K. grants from NIH, WL Gore, and BTG; personal fees from VIVA Physicians, Delcath, MarrowStim and COOK Medical; book royalties and journal editor stipend from Elsevier; section editor stipend from ARRS/AJR; stock ownership in Hatch Medical, Vu Medi, Endoshape, and Veniti; stock options in Javelin Medical, AV Medical, and BIO2 Medical. A.F., M.H., Y.J., Y.T., and K.H. declare that they have no competing interest.

AB - In their article, the authors wish to correct the presentation of Table 1. In addition, the authors wish to complete their disclosure statement. Disclosure of interests: Activities related to the present article: K.F. received a grant from Guerbet for this study. Activities not related to the present article: Y.M. a grant from Japan Radiological Society supported by Bayer Yakuhin; a consultancy fee from Stryker Japan; a lecture's fee from Terumo Corporation. J.A.K. grants from NIH, WL Gore, and BTG; personal fees from VIVA Physicians, Delcath, MarrowStim and COOK Medical; book royalties and journal editor stipend from Elsevier; section editor stipend from ARRS/AJR; stock ownership in Hatch Medical, Vu Medi, Endoshape, and Veniti; stock options in Javelin Medical, AV Medical, and BIO2 Medical. A.F., M.H., Y.J., Y.T., and K.H. declare that they have no competing interest.

UR - http://www.scopus.com/inward/record.url?scp=85042905309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042905309&partnerID=8YFLogxK

U2 - 10.1016/j.diii.2018.01.015

DO - 10.1016/j.diii.2018.01.015

M3 - Comment/debate

VL - 99

SP - 183

EP - 184

JO - Diagnostic and interventional imaging

JF - Diagnostic and interventional imaging

SN - 2211-5684

IS - 3

ER -